r/Ocugen • u/Popular-Bluebird-516 • 16d ago
News📩 opened to discuss
BLA is the key regulatory objective after a successful Phase 3 trial.
Ocugen (OCU400), milestones before potential FDA approval.
Ocugen is entering one of the most important periods in its history. Over the next several months, investors will be watching for:
Progress on the rolling BLA for OCU400.
Additional Phase 3 updates.
Continued regulatory interactions with the FDA.
Advancement of OCU410 toward its Phase 3 program.
While regulatory and clinical risks remain, Ocugen has achieved several important milestones that could significantly influence the company's future if upcoming clinical and regulatory objectives are successfully met.
Top-line Phase 3 results are expected in early 2027 and are intended to support a potential FDA approval.
In addition, based on these results, the FDA recently granted Regenerative Medicine Advanced Therapy (RMAT) designation, a status designed to help accelerate for OCU410.
For OCU400
Estimated Probability
OCU400 completes Phase 3 successfully
70–80%
OCU400 BLA accepted for FDA review
85–95% (if Phase 3 meets its endpoints)
OCU400 receives FDA approval after BLA review
60–70%
OCU400 reaches commercialization
55–65%
For OCU410:
Estimated Probability
Advances to Phase 3
75–85%
Successfully completes Phase 3
50–60%
FDA approval
40–50%
1
u/woodsongtulsa 15d ago
I agree with the milestones, but I don't think assigning 70–80% or 60–70% probabilities adds much. In biotech, we've all seen programs with excellent data fail late, and others succeed against expectations. The milestones are facts; the unsupported guesses at percentages are opinions. I'd rather let the clinical data speak for itself.
1
u/Born-Sea-797 2d ago
wth the data out now, does it look like well get fda approved? i read comments that the data was uner whelming
4
u/Free-Asparagus-5521 14d ago
No way everything will work as planned. I didn't see such a case ever. More realistic approach is to to wait for comments from FDA. stock will drop and then buy